[1]
W. Rajabto and N. Joenputri, “Additional Chromosomal Abnormalities in Chronic Myeloid Leukemia Patient Treated with First-Line Tyrosine Kinase Inhibitor Therapy: Good or Poor Prognosis?”, Acta Med Indones, vol. 54, no. 4, p. 603, Jan. 2023.